MMP2-9 cleavage of dystroglycan alters the size and molecular composition of Schwann cell domains

Journal of Neuroscience

Volumn 31, Issue 34, 2011, Pages 12208-12217

  Court, Felipe A ^a   Zambroni, Desirée ^a   Pavoni, Ernesto ^a   Colombelli, Cristina ^a   Baragli, Chiara ^a   Figlia, Gianluca ^a   Sorokin, Lydia ^b   Ching, William ^c   Salzer, James L ^c   Wrabetz, Lawrence ^a   Laura Feltri, M ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DYSTROGLYCAN; GELATINASE A; GELATINASE B;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COMPARTMENTALIZATION; CHEMICAL COMPOSITION; CONGENITAL MUSCULAR DYSTROPHY 1A; CONTROLLED STUDY; CYTOPLASM; EMBRYO; MOUSE; MUSCULAR DYSTROPHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN LOCALIZATION; RAT; SCHWANN CELL;

ANIMALS; CELL COMPARTMENTATION; CELLS, CULTURED; COCULTURE TECHNIQUES; DISEASE MODELS, ANIMAL; DYSTROGLYCANS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYELIN SHEATH; NERVE FIBERS, MYELINATED; PROTEIN INTERACTION DOMAINS AND MOTIFS; RATS; SCHWANN CELLS; SCIATIC NERVE;

EID: 80051937261     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.0141-11.2011     Document Type: Article

References (73)

1. Adams ME, Tesch Y, Percival JM, Albrecht DE, Conhaim JI, Anderson K, Froehner SC (2008) Differential targeting of nNOS and AQP4 to dystrophindeficient sarcolemma by membrane-directed alpha-dystrobrevin. J Cell Sci 121:48-54.
2. Agrawal S, Anderson P, Durbeej M, van Rooijen N, Ivars F, Opdenakker G, Sorokin LM (2006) Dystroglycan is selectively cleaved at the parenchymal basement membrane at sites of leukocyte extravasation in experimental autoimmune encephalomyelitis. J Exp Med 203:1007-1019.
3. Akhavan A, Crivelli SN, Singh M, Lingappa VR, Muschler JL (2008) SEA domain proteolysis determines the functional composition of dystroglycan. FASEB J 22:612-621.
4. Albrecht DE, Sherman DL, Brophy PJ, Froehner SC (2008) The ABCA1 cholesterol transporter associates with one of two distinct dystrophinbased scaffolds in Schwann cells. Glia 56:611-618.
5. Bergers G, Hanahan D, Coussens LM (1998) Angiogenesis and apoptosis are cellular parameters of neoplastic progression in transgenic mouse models of tumorigenesis. Int J Dev Biol 42:995-1002.
6. Bonuccelli G, Sotgia F, Schubert W, Park DS, Frank PG, Woodman SE, Insabato L, Cammer M, Minetti C, Lisanti MP (2003) Proteasome inhibitor (MG-132) treatment of mdx mice rescues the expression and membrane localization of dystrophin and dystrophin-associated proteins. Am J Pathol 163:1663-1675.
7. Bozzi M, Morlacchi S, Bigotti MG, Sciandra F, Brancaccio A (2009) Functional diversity of dystroglycan. Matrix Biol 28:179-187.
8. Bradley WG, JenkisonM (1973) Abnormalities of peripheral nerves in murine muscular dystrophy. J Neurol Sci 18:227-247.
9. Bragg AD, Amiry-Moghaddam M, Ottersen OP, Adams ME, Froehner SC (2006) Assembly of a perivascular astrocyte protein scaffold at the mammalian blood-brain barrier is dependent on alpha-syntrophin. Glia 53:879-890.
10. Cai H, Erdman RA, Zweier L, Chen J, Shaw JH 4th, Baylor KA, Stecker MM, Carey DJ, Chan YM (2007) The sarcoglycan complex in Schwann cells and its role in myelin stability. Exp Neurol 205:257-269.
11. Chattopadhyay S, Myers RR, Janes J, Shubayev V (2007) Cytokine regulation of MMP-9 in peripheral glia: implications for pathological processes and pain in injured nerve. Brain Behav Immun 21:561-568.
12. Chen YJ, Spence HJ, Cameron JM, Jess T, Ilsley JL, Winder SJ (2003) Direct interaction of beta-dystroglycan with F-actin. Biochem J 375:329-337.
13. Connors NC, Adams ME, Froehner SC, Kofuji P (2004) The potassium channel Kir4.1 associates with the dystrophin-glycoprotein complex via alpha-syntrophin in glia. J Biol Chem 279:28387-28392.
14. Court F, Alvarez J (2000) Nerve regeneration in Wld(s) mice is normalized by actinomycin D. Brain Res 867:1-8.
15. Court FA, Hewitt JE, Davies K, Patton BL, Uncini A, Wrabetz L, Feltri ML (2009) A laminin-2, dystroglycan, utrophin axis is required for compartmentalization and elongation of myelin segments. J Neurosci 29:3908-3919.
16. Court FA, Sherman DL, Pratt T, Garry EM, Ribchester RR, Cottrell DF, Fleetwood-Walker SM, Brophy PJ (2004) Restricted growth of Schwann cells lacking Cajal bands slows conduction in myelinated nerves. Nature 431:191-195.
17. Di Muzio A, De Angelis MV, Di Fulvio P, Ratti A, Pizzuti A, Stuppia L, Gambi D, Uncini A (2003) Dysmyelinating sensory-motor neuropathy in merosin-deficient congenital muscular dystrophy. Muscle Nerve 27:500-506.
18. Dubois B, Masure S, Hurtenbach U, Paemen L, Heremans H, van den Oord J, Sciot R, Meinhardt T, Hämmerling G, Opdenakker G, Arnold B (1999) Resistance of young gelatinase B-deficient mice to experimental autoimmune encephalomyelitis and necrotizing tail lesions. J Clin Invest 104:1507-1515.
19. Einheber S, Zanazzi G, Ching W, Scherer S, Milner TA, Peles E, Salzer JL (1997) The axonal membrane protein Caspr, a homologue of neurexin IV, is a component of the septate-like paranodal junctions that assemble during myelination. J Cell Biol 139:1495-1506.
20. Feltri ML, D'Antonio M, Previtali S, Fasolini M, Messing A, Wrabetz L (1999) P0-Cre transgenic mice for inactivation of adhesion molecules in Schwann cells. Ann N Y Acad Sci 883:116-123.
21. Ferguson TA, Muir D (2000) MMP-2 and MMP-9 increase the neuritepromoting potential of schwann cell basal laminae and are upregulated in degenerated nerve. Mol Cell Neurosci 16:157-167.
22. Gazzerro E, Assereto S, Bonetto A, Sotgia F, Scarfi S, Pistorio A, Bonuccelli G, Cilli M, Bruno C, Zara F, Lisanti MP, Minetti C (2010) Therapeutic potential of proteasome inhibition in Duchenne and Becker muscular dystrophies. Am J Pathol 176:1863-1877.
23. Grady RM, Zhou H, Cunningham JM, Henry MD, Campbell KP, Sanes JR (2000) Maturation and maintenance of the neuromuscular synapse: genetic evidence for roles of the dystrophin-glycoprotein complex. Neuron 25:279-293.
24. Haenggi T, Fritschy JM (2006) Role of dystrophin and utrophin for assembly and function of the dystrophin glycoprotein complex in non-muscle tissue. Cell Mol Life Sci 63:1614-1631.
25. Herzog C, Has C, Franzke CW, Echtermeyer FG, Schlötzer-Schrehardt U, Kröger S, Gustafsson E, Fässler R, Bruckner-Tuderman L (2004) Dystroglycan in skin and cutaneous cells: beta-subunit is shed from the cell surface. J Invest Dermatol 122:1372-1380.
26. Hiscoe HB (1947) Distribution of nodes and incisures in normal and regenerated nerve fibers. Anat Rec 99:447-475.
27. Holt KH, Crosbie RH, Venzke DP, Campbell KP (2000) Biosynthesis of dystroglycan: processing of a precursor propeptide. FEBS Lett 468:79-83.
28. Ibraghimov-Beskrovnaya O, Ervasti JM, Leveille CJ, Slaughter CA, Sernett SW, Campbell KP (1992) Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix. Nature 355:696-702.
29. Itoh T, Ikeda T, Gomi H, Nakao S, Suzuki T, Itohara S (1997) Unaltered secretion of beta-amyloid precursor protein in gelatinase A (matrix metalloproteinase 2)-deficient mice. J Biol Chem 272:22389-22392.
30. Jaros E, Jenkison M (1983) Quantitative studies of the abnormal axon- Schwann cell relationship in the peripheral motor and sensory nerves of the dystrophic mouse. Brain Res 258:181-196.
31. Jensen TJ, Loo MA, Pind S, Williams DB, Goldberg AL, Riordan JR (1995) Multiple proteolytic systems, including the proteasome, contribute to CFTR processing. Cell 83:129-135.
32. Jing J, Lien CF, Sharma S, Rice J, Brennan PA, Gó recki DC (2004) Aberrant expression, processing and degradation of dystroglycan in squamous cell carcinomas. Eur J Cancer 40:2143-2151.
33. Kherif S, Dehaupas M, Lafuma C, Fardeau M, Alameddine HS (1998) Matrix metalloproteinases MMP-2 and MMP-9 in denervated muscle and injured nerve. Neuropathol Appl Neurobiol 24:309-319.
34. Kidd GJ, Andrews SB, Trapp BD (1994) Organization of microtubules in myelinating Schwann cells. J Neurocytol 23:801-810.
35. Kopan R, Ilagan MX (2009) The canonical Notch signaling pathway: unfolding the activation mechanism. Cell 137:216-233.
36. La Fleur M, Underwood JL, Rappolee DA, Werb Z (1996) Basement membrane and repair of injury to peripheral nerve: defining a potential role for macrophages, matrix metalloproteinases, and tissue inhibitor of metalloproteinases-1. J Exp Med 184:2311-2326.
37. Lane PW, Beamer TC, Myers DD (1976) Myodystrophy, a new myopathy on chromosome 8 of the mouse. J Hered 67:135-138.
38. Li H, Mittal A, Makonchuk DY, Bhatnagar S, Kumar A (2009) Matrix metalloproteinase-9 inhibition ameliorates pathogenesis and improves skeletal muscle regeneration in muscular dystrophy. Hum Mol Genet 18:2584-2598.
39. Losasso C, Di Tommaso F, Sgambato A, Ardito R, Cittadini A, Giardina B, Petrucci TC, Brancaccio A (2000) Anomalous dystroglycan in carcinoma cell lines. FEBS Lett 484:194-198.
40. Matsumura K, Arai K, Zhong D, Saito F, Fukuta-Ohi H, Maekawa R, Yamada H, Shimizu T (2003) Disruption of dystroglycan axis by beta-dystroglycan processing in cardiomyopathic hamster muscle. Neuromuscul Disord 13:796-803.
41. Michaluk P, Kolodziej L, Mioduszewska B, Wilczynski GM, Dzwonek J, Jaworski J, Gorecki DC, Ottersen OP, Kaczmarek L (2007) Betadystroglycan as a target for MMP-9, in response to enhanced neuronal activity. J Biol Chem 282:16036-16041.
42. Mirowska D, Członkowska A (2001) The role of metalloprotease in pathogenesis of nervous system diseases (in Polish). Neurol Neurochir Pol 35:101-110.
43. Moore CJ, Winder SJ (2010) Dystroglycan versatility in cell adhesion: a tale of multiple motifs. Cell Commun Signal 8:3.
44. Neely JD, Amiry-Moghaddam M, Ottersen OP, Froehner SC, Agre P, Adams ME (2001) Syntrophin-dependent expression and localization of Aquaporin-4 water channel protein. Proc Natl Acad Sci U S A 98:14108-14113.
45. Nodari A, Zambroni D, Quattrini A, Court FA, D'Urso A, Recchia A, Tybulewicz VL, Wrabetz L, Feltri ML (2007) Beta1 integrin activates Rac1 in Schwann cells to generate radial lamellae during axonal sorting and myelination. J Cell Biol 177:1063-1075.
46. Nodari A, Previtali SC, Dati G, Occhi S, Court FA, Colombelli C, Zambroni D, Dina G, Del Carro U, Campbell KP, Quattrini A, Wrabetz L, Feltri ML (2008) Alpha6beta4 integrin and dystroglycan cooperate to stabilize the myelin sheath. J Neurosci 28:6714-6719.
47. Occhi S, Zambroni D, Del Carro U, Amadio S, Sirkowski EE, Scherer SS, Campbell KP, Moore SA, Chen ZL, Strickland S, Di Muzio A, Uncini A, Wrabetz L, Feltri ML (2005) Both laminin and Schwann cell dystroglycan are necessary for proper clustering of sodium channels at nodes of Ranvier. J Neurosci 25:9418-9427.
48. O'Reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, Lane WS, Flynn E, Birkhead JR, Olsen BR, Folkman J (1997) Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88:277-285.
49. Page-McCaw A, Ewald AJ, Werb Z (2007) Matrix metalloproteinases and the regulation of tissue remodelling. Nat Rev Mol Cell Biol 8:221-233.
50. Ramóny Cajal S (1933) Histology. London: Bailliere, Tindall and Cox.
51. Rezniczek GA, Konieczny P, Nikolic B, Reipert S, Schneller D, Abrahamsberg C, Davies KE, Winder SJ, Wiche G (2007) Plectin 1f scaffolding at the sarcolemma of dystrophic (mdx) muscle fibers through multiple interactions with beta-dystroglycan. J Cell Biol 176:965-977.
52. Roberds SL, Ervasti JM, Anderson RD, Ohlendieck K, Kahl SD, Zoloto D, Campbell KP (1993) Disruption of the dystrophin-glycoprotein complex in the cardiomyopathic hamster. J Biol Chem 268:11496-11499.
53. Saito F, Masaki T, Kamakura K, Anderson LV, Fujita S, Fukuta-Ohi H, Sunada Y, Shimizu T, Matsumura K (1999) Characterization of the transmembrane molecular architecture of the dystroglycan complex in schwann cells. J Biol Chem 274:8240-8246.
54. Saito F, Moore SA, Barresi R, Henry MD, Messing A, Ross-Barta SE, Cohn RD, Williamson RA, Sluka KA, Sherman DL, Brophy PJ, Schmelzer JD, Low PA, Wrabetz L, Feltri ML, Campbell KP (2003) Unique role of dystroglycan in peripheral nerve myelination, nodal structure, and sodium channel stabilization. Neuron 38:747-758.
55. Salzer JL (2003) Polarized domains of myelinated axons. Neuron 40:297-318.
56. Shang ZJ, Ethunandan M, Górecki DC, Brennan PA (2008) Aberrant expression of beta-dystroglycan may be due to processing by matrix metalloproteinases-2 and-9 in oral squamous cell carcinoma. Oral Oncol 44:1139-1146.
57. Sherman DL, Brophy PJ (2000) A tripartite nuclear localization signal in the PDZ-domain protein L-periaxin. J Biol Chem 275:4537-4540.
58. Sherman DL, Fabrizi C, Gillespie CS, Brophy PJ (2001) Specific disruption of a schwann cell dystrophin-related protein complex in a demyelinating neuropathy. Neuron 30:677-687.
59. Shubayev VI, Myers RR (2000) Upregulation and interaction of TNFalpha and gelatinases A and B in painful peripheral nerve injury. Brain Res 855:83-89.
60. Shubayev VI, Angert M, Dolkas J, Campana WM, Palenscar K, Myers RR (2006) TNFalpha-induced MMP-9 promotes macrophage recruitment into injured peripheral nerve. Mol Cell Neurosci 31:407-415.
61. Singh J, Itahana Y, Knight-Krajewski S, Kanagawa M, Campbell KP, Bissell MJ, Muschler J (2004) Proteolytic enzymes and altered glycosylation modulate dystroglycan function in carcinoma cells. Cancer Res 64:6152-6159.
62. Sottile J (2004) Regulation of angiogenesis by extracellular matrix. Biochim Biophys Acta 1654:13-22.
63. Straub V, Duclos F, Venzke DP, Lee JC, Cutshall S, Leveille CJ, Campbell KP (1998) Molecular pathogenesis of muscle degeneration in the deltasarcoglycan- deficient hamster. Am J Pathol 153:1623-1630.
64. Thompson O, Moore CJ, Hussain SA, Kleino I, Peckham M, Hohenester E, Ayscough KR, Saksela K, Winder SJ (2010) Modulation of cell spreading and cell-substrate adhesion dynamics by dystroglycan. J Cell Sci 123:118-127.
65. Triolo D, Cerri F, Taveggia C, Porrello E, Bolino A, Colombelli C, Feltri ML, Dina G, D'adamo P, Del Carro U, Morana P, Sherman DL, Babinet C, Quattrini A, Previtali SC (2009) Abnormal Schwann cell-axon units and myelination in vimentin-deficient mice. In: Peripheral Nerve Society Meeting (Wiley I, ed), pp 1-163.Würzburg, Germany: Journal of the Peripheral Nervous System.
66. Vu TH, Shipley JM, Bergers G, Berger JE, Helms JA, Hanahan D, Shapiro SD, Senior RM, Werb Z (1998) MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 93:411-422.
67. Weir ML, Oppizzi ML, Henry MD, Onishi A, Campbell KP, Bissell MJ, Muschler JL (2006) Dystroglycan loss disrupts polarity and beta-casein induction in mammary epithelial cells by perturbing laminin anchoring. J Cell Sci 119:4047-4058.
68. Wrabetz L, Feltri ML (2001) Do Schwann cells stop, DR(o)P2, and roll? Neuron 30:642-644.
69. Wrabetz L, Feltri ML, Quattrini A, Imperiale D, Previtali S, D'Antonio M, Martini R, Yin X, Trapp BD, Zhou L, Chiu SY, Messing A (2000) P(0) glycoprotein overexpression causes congenital hypomyelination of peripheral nerves. J Cell Biol 148:1021-1034.
70. Wu CY, Hsieh HL, Sun CC, Yang CM (2009) IL-1beta induces MMP-9 expression via a Ca 2_-dependent CaMKII/JNK/c-JUN cascade in rat brain astrocytes. Glia 57:1775-1789.
71. Yamada H, Saito F, Fukuta-Ohi H, Zhong D, Hase A, Arai K, Okuyama A, Maekawa R, Shimizu T, Matsumura K (2001) Processing of betadystroglycan by matrix metalloproteinase disrupts the link between the extracellular matrix and cell membrane via the dystroglycan complex. Hum Mol Genet 10:1563-1569.
72. Zhao XL, Li GZ, Sun B, Zhang ZL, Yin YH, Tian YS, Li H, Li HL, Wang de S, Zhong D (2010) MMP-mediated cleavage of beta-dystroglycan in myelin sheath is involved in autoimmune neuritis. Biochem Biophys Res Commun 392:551-556.
73. Zhong D, Saito F, Saito Y, Nakamura A, Shimizu T, Matsumura K (2006) Characterization of the protease activity that cleaves the extracellular domain of beta-dystroglycan. Biochem Biophys Res Commun 345: 867-871.